RE: Interesting trades12 Nov 2022 11:44
Aquae, the vip’s get the lysate. The point is, it’s our technology (the manufacturing process) which enables the lysate to exist. You have to forget the end product, we have done a deal on the technology. This isn’t one product, this will be multiple products.
Croda to design and manufacture a new active skincare ingredient based on SkinBiotix(TM) technology and investigate specific cosmetic ingredient applications to target
Sederma, the division of Croda Plc that specialises in the manufacture of bioactive ingredients for the cosmetic industry, has updated the Company on progress of its ongoing collaboration and confirmed that;
-- Sederma has successfully replicated the lysate manufacturing process and achieved the same performance from the SkinBiotix(R) technology as established by the Company
-- Sederma is now working to validate scale up of the manufacturing process at different volume levels.
Sederma will be responsible for the development, manufacture and commercialisation of the SkinBiotix (R) technology, with any products resulting from this programme being sold to Croda's global portfolio of Personal Care customers. SkinBioTherapeutics will be paid tiered royalties based on global sales revenues on any licensed products derived from the partnership.
"We have seen significant positive progress made on the first of our commercial programmes in recent weeks. In such an important scientific milestone, it is reassuring and provides validation of our approach that Sederma has been able to replicate the activity of the SkinBiotix technology and is pushing ahead with the next steps of the project.